NASDAQ:NBIX opened at $151.82 on Thursday. Neurocrine Biosciences has a fifty-two week low of $110.95 and a fifty-two week high of $157.98. The company has a 50 day moving average price of $136.97 ...

A number of large investors have recently bought and sold ... after buying an additional 363,863 shares during the period. Braidwell LP boosted its stake in Neurocrine Biosciences by 20.9% in ...

But it needs money to do so: 40 billion US dollars. OpenAI continues to look for new investors. As the Wall Street Journal reports, they specifically need 40 billion US dollars. This would ...

Analyst and Investor Day to be held on February 6 at 9 am. Webcast Link Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the ...

Diageo's new finance chief Nik Jhangiani is under pressure to row back on the spirits giant's medium-term sales goals next week, which some investors say may no longer be realistic given sliding ...

These 10 individuals are helping blaze a trail for future Black investors Kiara Taylor has worked as a financial analyst for more than a decade. Her career has involved a number of financial ...

The scale of the returns would surpass even the blockbuster total handed to investors in 2023, as executives seek to share bumper profits earned as interest rates rose rapidly and to compensate ...

Company cuts upper valuation guidance to $65 bln from $110 bln Investors balked at long-term sales guidance in IPO prospectus IPO a rare opportunity to buy equity in U.S. LNG exporter Also seen as ...

Investors may be mispricing a handful of things that are being factored into market outlooks in 2025, according to Deutsche Bank. In a note to clients on Tuesday, the bank pointed to three of the ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...